Key result
Pharmacologic rhythm control for new-onset atrial fibrillation in noncardiac ICU patients lacks sufficient evidence to recommend a standard treatment due to methodological heterogeneity.
Why the study?
Do pharmacologic rhythm conversion regimens improve atrial fibrillation resolution in noncardiac critically ill adults?
Systematic Review (n=143)
Do pharmacologic rhythm conversion regimens improve atrial fibrillation resolution in noncardiac critically ill adults?
There is insufficient evidence from randomized trials to recommend a standard pharmacologic rhythm control strategy for new-onset atrial fibrillation in noncardiac critically ill patients.
No takes yet. Share an insight, caveat, or question.
Insufficient evidence precludes recommending any pharmacologic rhythm control strategy for new-onset AF in noncardiac ICU patients; leaves open the need for homogeneous RCTs.
Kanji et al. (2008) conducted a systematic review in New-onset atrial fibrillation in noncardiac critically ill adults (n=143). Pharmacologic rhythm control was evaluated on Atrial fibrillation resolution. Pharmacologic rhythm control for new-onset atrial fibrillation in noncardiac ICU patients lacks sufficient evidence to recommend a standard treatment due to methodological heterogeneity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: